000 | 01925 a2200505 4500 | ||
---|---|---|---|
005 | 20250515023233.0 | ||
264 | 0 | _c20060810 | |
008 | 200608s 0 0 eng d | ||
022 | _a0006-8993 | ||
024 | 7 |
_a10.1016/j.brainres.2006.02.111 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKobori, Nobuhide | |
245 | 0 | 0 |
_aGDNF abates serum deprivation-induced tyrosine hydroxylase Ser19 phosphorylation and activity. _h[electronic resource] |
260 |
_bBrain research _cMay 2006 |
||
300 |
_a142-51 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlotting, Western _xmethods |
650 | 0 | 4 | _aCalcium-Calmodulin-Dependent Protein Kinase Type 2 |
650 | 0 | 4 |
_aCalcium-Calmodulin-Dependent Protein Kinases _xmetabolism |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCulture Media, Serum-Free _xpharmacology |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aEmbryo, Mammalian |
650 | 0 | 4 |
_aExcitatory Amino Acid Agonists _xpharmacology |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 |
_aGlial Cell Line-Derived Neurotrophic Factor _xmetabolism |
650 | 0 | 4 |
_aGlutamic Acid _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMesencephalon _xcytology |
650 | 0 | 4 |
_aN-Methylaspartate _xpharmacology |
650 | 0 | 4 | _aNeuroblastoma |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 |
_aSerine _xmetabolism |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
700 | 1 | _aMoore, Anthony N | |
700 | 1 | _aDash, Pramod K | |
773 | 0 |
_tBrain research _gvol. 1086 _gno. 1 _gp. 142-51 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2006.02.111 _zAvailable from publisher's website |
999 |
_c16230845 _d16230845 |